Abel Viejo‐Borbolla

Author

Abel Viejo‐Borbolla

Medizinische Hochschule Hannover ORCID

Also Known As

A Viejo-Borbolla, A. Viejo-Borbolla, Abel Viejo-Borbolla, Abel Viejo‐Borbolla, Abel Viejo–Borbolla

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover Consejo Superior de Investigaciones Científicas Universidad Autónoma de Madrid Centro de Biología Molecular Severo Ochoa German Center for Infection Research

About

Abel Viejo‐Borbolla is an author at Medizinische Hochschule Hannover specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	845
2	Cell Biology	13	13	672
3	Natural Sciences	3	3	329
4	Biomolecular Engineering	2	2	91
5	Cellular Physiology	1	1	31

Abel Viejo‐Borbolla

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G <sub>1</sub> Cell CycleArrest Matthias Ottinger, Thomas Christalla, Kavita Nathan, Journal of Virology Viral ReplicationImmunologyPathologyShort VariantCell Cycle	2006	145
Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 Abel Viejo‐Borbolla, Matthias Ottinger, Eva Brüning, Journal of Virology Viral ReplicationImmunologyPathologyViral Structural ProteinEpigenetics	2005	121
The Ubiquitin-Specific Protease USP7 Modulates the Replication of Kaposi's Sarcoma-Associated Herpesvirus Latent Episomal DNA Wiebke Jäger, Susann Santag, Magdalena Weidner-Glunde, Journal of Virology Viral ReplicationPrimary Effusion LymphomaImmunologyPathologySarcoma Herpesvirus	2012	63
Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus Joanne M. Devlin, Abel Viejo‐Borbolla, Glenn F. Browning, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentImmunologyVirology	2009	59
Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. Abel Viejo‐Borbolla, Thomas F. Schulz PubMed Viral PersistencePrimary Effusion LymphomaPathogenesisImmunologyPathology	2004	55
A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin Abel Viejo‐Borbolla, Emrah Kati, Julie Sheldon, Journal of Virology	2003	51
Enhancement of Chemokine Function as an Immunomodulatory Strategy Employed by Human Herpesviruses Abel Viejo‐Borbolla, Nadia Martinez-Martín, Hendrik J. Nel, PLoS Pathogens ImmunologyViral PathogenesisChemokine FunctionViral Structural ProteinImmune System	2012	50
Glycoprotein G from pseudorabies virus binds to chemokines with high affinity and inhibits their function Abel Viejo‐Borbolla, Alberto Múñoz, E. Tabarés Journal of General Virology GlycobiologyImmunologyViral PathogenesisChemokine-binding ActivityViral Structural Protein	2009	41
Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex Maria Roupelieva, Stephen Griffiths, Elisabeth Kremmer, Journal of General Virology Serum Response ElementImmunologyPathologyViral Structural ProteinImmunotherapy	2010	39
Inner tegument proteins of Herpes Simplex Virus are sufficient for intracellular capsid motility in neurons but not for axonal targeting Anna Buch, Oliver Müller, Lyudmila Ivanova, PLoS Pathogens Viral ReplicationViral PathogenesisMolecular BiologyCytoskeletonViral Structural Protein	2017	39

Page 1